自然杀伤细胞治疗在血液肿瘤中的应用与挑战
- 1 中国医学科学院血液病医院(中国医学科学院血液学研究所),血液与健康全国重点实验室,国家血液系统疾病临床医学研究中心,细胞生态海河实验室,天津 300020
- 2 天津医学健康研究院,天津 301600
- 3 天津医科大学,细胞生态海河实验室,天津 300070
摘要
Applications and challenges of natural killer cell therapy in hematological malignancies
- 1 State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
- 2 Tianjin Institutes of Health Sciences, Tianjin 301600, China
- 3 Haihe Laboratory of Cell Ecosystem, Tianjin Medical University, Tianjin 300070, China
Abstract
Natural killer (NK) cells have demonstrated substantial therapeutic potential in cancer treatment, positioning them as a major focus in the field of immunotherapy. Owing to their unique major histocompatibility complex (MHC) independent cytotoxic activity, NK cells represent an ideal platform for the development of “off-the-shelf” cell-based therapies. However, the clinical application of NK cells still faces several critical challenges, including functional suppression by the tumor microenvironment, limited in vivo persistence, and difficulties in genetic modification. Gene editing technologies, particularly clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR associated protein 9 (Cas9), are progressively transforming the paradigm of genetic engineering and have greatly advanced both basic and clinical research in tumor immunotherapy. This article reviews the biological characteristics of NK cells, their genetic engineering strategies, and their applications in immunotherapy for hematological malignancies, and further discusses the challenges they face and future development directions.
